Why More Men Are Choosing Motivated for Fast and Effective ED Treatment
Motivated is a reliable telehealth platform that provides fast, safe, and effective ED treatment options while also giving ...
i1d
Sexual dysfunction and suicidal thoughts – the dark side of anti-balding drugs
Thousands of men claim finasteride, a drug that many start taking in their 20s and 30s to avoid hair loss, has left them with ...
Eli Lilly and Novo want to shake off Ozempic copycats. Are they ready to meet demand?
The makers of Ozempic and Zepbound are fighting to stop compounded copies of their drugs. But it’s unclear whether they can ...
Hims & Hers: Revolutionizing Telehealth And Captivating Investors - Here's Why You Should Buy
Hims & Hers offers personalized telehealth services, with a stock price that reflects high-growth potential. See why we ...
Amazon Gets Into the Boner Pill Business, Hims Stock Goes Limp
Amazon acquired primary care provider One Medical for $3.9 billion in 2022, and fills prescriptions through Amazon One ...
Hims & Hers stock tanks as Amazon debuts fixed pricing for hair-loss and erectile-dysfunction drugs
Hims & Hers Health, a telehealth service for clients to access healthcare and prescriptions from home, is seeing its stock ...
Hims & Hers' stock tumbles on Amazon's latest disruptive foray into healthcare
Hims & Hers Health Inc. shares tumbled 22% Thursday, on concerns that Amazon.com Inc.'s latest push into healthcare will disrupt Hims & Hers' business.
Amazon Will Start Selling Cheap Hair-Loss Drugs. It’s a Huge Threat for This Stock.
The tech company’s prices appear set to undercut the long list of competing telehealth companies that rely on aggressive ...
Hims & Hers cut to underperform by BoA over Amazon competition
BofA lowered its rating of Hims & Hers (HIMS) to underperform from buy, citing Amazon’s (AMZN) push into the hair loss and ...